Landscapes / Companies
Ribocure Pharmaceuticals AB not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 2
Drugs
4
in active trials · 5 in all
Trials
5 active
6 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 31 May 2027Phase 2 trial completes | |||
| Next date | 31 May 2027 · Phase 2 trial completes | ||||
| Also tested for | Dyslipidemias | ||||
| Open drug page | |||||
Small interfering RNA |
Phase 2 | Jul 2027Phase 2 trial completes | |||
| How it works | A short strand of RNA that switches off one gene | ||||
| Next date | Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Venous Thromboembolism (VTE), Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Sep 2027Phase 2 trial completes | |||
| Next date | 30 Sep 2027 · Phase 2 trial completes | ||||
| Also tested for | Stable Coronary Artery Disease | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Chronic Hepatitis D | ||||
| Open drug page | |||||
About
- No active trial
- RBD4059
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021